Hospital operating margin, measured year-to-date with health-system allocations, stood at 1.4% through July 2026 -- below the 2.5% reported through April and below the approximately 3.6% full-year operating margin reported for 2025, according to Kaufman Hall's National Hospital Flash Report, which draws on data from more than 1,300 hospitals via Strata Decision Technology. July's single-month operating margin was 1.1%. The trend is weak, but the figures must be handled precisely: year-to-date margins, monthly margins, and measures with or without health-system allocations are not interchangeable. The 1.4% figure is a calendar-year-to-date result through July -- not a full-year forecast -- and should be compared cautiously with April's year-to-date margin and 2025's full-year margin.

The margin path has been uneven: Kaufman Hall reported adjusted year-to-date margin of 1.3% in February, 1.7% in March, 2.5% in April, and 1.4% in July. Fitch's August 2026 median report shows the rated nonprofit sector entering 2027 from a somewhat stronger base than the Kaufman Hall July snapshot alone suggests: median overall operating margin rose to 1.5% from 1.1%, the third consecutive year of improvement, while liquidity and leverage remained generally stable. But Fitch also warned that OBBBA-related Medicaid eligibility and funding changes could weaken payer mix beginning in 2027 and test that resilience. The budget question is therefore not whether every hospital faces deterioration; it is whether the organization has enough margin and liquidity to absorb divergent cost, payer-mix, and policy pressures.

The error most 2027 operating plans will make is treating that 1.4% as one number with one driver. Hospital finance teams are managing separate pressures that require separate 2027 assumptions: labor costs, drug and supply inflation, insured patient responsibility and uncompensated care, and state-specific Medicaid eligibility risk.

Separate the Cost Stack From the Payer-Mix Line

Start with labor, because it is the one line showing something closer to moderation than crisis. Labor cost growth moderated from the extreme post-pandemic contract-labor environment, but remained above general inflation. The American Hospital Association's 2025 Cost of Caring report puts overall hospital workforce cost growth at 5.6%, with registered nurse salary growth averaging 5.5% over the trailing two years -- elevated relative to general inflation, but no longer accelerating. These are full-year 2025 figures, not 2026 run-rate. Systems should test whether their contract-labor assumptions reflect their current local staffing mix, vacancy rates, labor contracts, and agency dependence rather than carrying forward a uniform pandemic-era premium or these 2025 benchmarks unadjusted.

Non-labor is the harder line to model, precisely because Kaufman Hall reports it as a blended aggregate -- drug and supply spend combined, up year-over-year in 2026 -- without a public split between the two [verify: current 2026 year-to-date drug-only versus supply-only expense growth, decomposed]. The AHA's 2025 Cost of Caring report gives a usable proxy for the split: hospital drug expense grew 13.6% for the full year, with academic medical centers seeing drug costs surge 21.6%, while total supply spend rose 9.9%. Again, these are 2025 historical benchmarks, not 2026 run-rate. CFOs should not carry them forward unadjusted -- but they support building drug cost and supply cost as two separate assumption rows rather than one "non-labor inflation" plug. A hospital with a drug-intensive service line (oncology, transplant, specialty infusion) is exposed very differently than one whose non-labor cost growth is concentrated in general medical-surgical supplies, purchased services, maintenance, or equipment-related operating expense, and a blended assumption obscures which lever actually moves the number.

Payer-Mix Erosion Is Already in the P&L

Earlier 2026 Kaufman Hall reporting found bad debt and charity care per calendar day up 16% year over year in May. By July, related Strata data showed bad debt and charity care per day up 14% year over year and bad debt and charity care as a share of gross operating revenue up 5% year over year [verify: confirm the exact July Kaufman Hall or Strata figures directly against the published July 2026 Flash Report before attributing specific percentages -- confirm which metric is per-day dollar growth versus year-to-date totals versus share of revenue, as these are not interchangeable].

Whatever the exact July figure, the direction is consistent with what is occurring in the individual marketplace. Before the enhanced premium tax credits expired at the end of 2025, KFF estimated that subsidized Marketplace enrollees who kept the same plan could see average premium payments rise 114% in 2026, from roughly $888 to $1,904 annually. Actual effects vary because some enrollees selected lower-premium plans, changed metal tiers, or dropped coverage altogether. The combined effect can appear downstream in hospital eligibility checks, patient-responsibility balances, self-pay volume, and bad debt before national year-end enrollment data fully capture the pattern. For 2027 budgeting, that means self-pay and charity-care assumptions should be flexed as a live variable tied to marketplace affordability, not held flat off a prior-year run rate.

The Medicaid Work-Requirement Rule Is a State Variable, Not a Calendar Date

CMS's interim final rule on Medicaid community engagement requirements (CMS-2454-IFC), issued in June 2026, sets January 1, 2027 as the date by which states must "generally" implement work and community-engagement requirements for the applicable population -- but the rule explicitly allows states to implement earlier, and it leaves states significant discretion over verification frequency, reporting infrastructure, and administration of a lengthy set of exclusions and exemptions, including pregnancy/postpartum status, certain caretaker responsibilities, medical frailty, tribal membership, former foster youth, veterans meeting the applicable disability standard, and other specified groups.

That combination -- a common backstop date, state-optional early adoption, and state-built verification systems -- means the actual bad-debt and self-pay exposure a given hospital sees in 2027 depends on each state's expansion population, implementation timetable, eligibility-system readiness, data-matching and verification design, outreach, renewal processes, and how the state operationalizes federally required exemptions and good-cause protections. States cannot simply choose to apply required exemptions more aggressively than the federal rule requires -- they must follow federal statutory and regulatory requirements -- though implementation design, data matching, renewal processes, notices, verification practices, and administrative capacity can affect coverage disruption.

A hospital system operating across two or three states should not budget a uniform "January 2027 Medicaid event" line. It should build a state-by-state scenario matrix tied to each state's actual implementation posture and affected enrollment, which in most cases is still being finalized as of this writing [verify: individual state implementation dates and verification-system readiness as each state publishes its plan].

Cash, Covenants, and the Payment Lag

The timing of Medicaid and Medicare supplemental payments is highly state-specific, and the relevant offset varies by mechanism. The relevant offset may be Medicaid DSH, a state-directed or other supplemental payment, a waiver-supported payment, Medicare uncompensated-care funding, or no offset at all; the timing and eligibility rules differ materially. In some states, cost-reporting, reconciliation, and payment cycles can create a material delay between rising uncompensated-care expense and any offsetting payment effect. CFOs should model the actual timing under their state's Medicaid plan, DSH methodology, waiver authorities, and hospital-payment schedule rather than assume a uniform lag [verify: current DSH and uncompensated-care payment reconciliation timing by state before modeling any specific lag into the 2027 budget].

Fitch's trifurcated view of the nonprofit sector -- a strong top tier, a stagnating middle, and a deteriorating bottom segment -- is a useful lens for deciding where that lag matters most: a system already near covenant thresholds has far less room to self-fund a timing gap than one sitting on ample days cash on hand.

None of this argues that any single policy or price trend caused the reset to 1.4%. It argues that the number has at least four separable inputs -- labor, drug, supply, and payer-mix/eligibility risk -- each with a different trajectory and a different degree of your organization's control.

The Budget Committee Question

The question for the budget committee is not whether margins will "normalize" in 2027. The sector is entering 2027 with mixed signals: Kaufman Hall's July operating results remain thin, while Fitch's rated-sector medians show a third consecutive year of improvement and still warn that Medicaid eligibility and funding changes could weaken payer mix. The operational question is whether your model isolates labor, drug costs, supply costs, Marketplace-related patient responsibility, and state-specific Medicaid eligibility exposure into separate assumptions with separate sensitivities. If they remain blended inside one "cost and payer mix" line, next July's variance report will show that something moved -- but not what, or what to do about it.